3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine

Catalog No. :
ACSJDQ216
CAS No. :
1046-56-6
Molecular Formula :
C20H14N4
Molecular Weight :
310.36

IUPAC Name:5,6-diphenyl-3-(pyridin-2-yl)-1,2,4-triazine

3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$56.00Login to see priceIn stockInquiry
25g98%$252.00Login to see priceIn stockInquiry
100g98%$927.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine
IUPAC Name5,6-diphenyl-3-(pyridin-2-yl)-1,2,4-triazine
MDL No.MFCD00006462
Molecular FormulaC20H14N4
Molecular Weight310.36
SMILESC1(C2=NC=CC=C2)=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N=N1
InChI KeyOTMYLOBWDNFTLO-UHFFFAOYSA-N
SynonymPDT | D84148 | 5,6-diphenyl-3-(pyridin-2-yl)-1,2,4-triazine | FT-0613588 | EINECS 213-878-7 | EU-0001368 | BIM-0025839.P001 | 5,6-di(phenyl)-3-pyridin-2-yl-1,2,4-triazine | BRN 0542151 | D1201 | SCHEMBL149565 | Bio7C7 | AS-64877 | DTXSID8061428 | 3-(2-Pyr
CAS No.1046-56-6
PubChem CID70588

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSJDQ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACSJDQ216 route product structure diagram
    ACSJDQ2161046-56-6 In Stock
Inquiry

2. ACSJDQ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACSJDQ216 route product structure diagram
    ACSJDQ2161046-56-6 In Stock
Inquiry

Comments (0)